GERN Q2 2022 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$73,000-31.8% YoY

Gross Profit

$73,000100.0% margin

Operating Income

-$28M-38323.3% margin

Net Income

-$28M-38516.4% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

-40.7%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$238M

Total Liabilities

$96M

Stockholders' Equity

$142M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$73,000	$107,000	-31.8%
Gross Profit	$73,000	-$22M	+100.3%
Operating Income	-$28M	-$29M	+3.2%
Net Income	-$28M	-$30M	+4.9%